Vnitr Lek 2009, 55(12):1193-1195

Starosti s hypertenzí a krevním tlakem vůbec

P. Jerie

Received: October 21, 2009; Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jerie P. Starosti s hypertenzí a krevním tlakem vůbec. Vnitr Lek. 2009;55(12):1193-1195.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Widimský J. Cílové hodnoty léčby hypertenze. Budou platit i u starších hypertoniků, diabetiků a u pacientů s ICHS? Vnitř Lék 2009; 55: 833-840. Go to PubMed...
    2. Chobanian AV. The hypertension paradox - more uncontrolled disease despite improved therapy. N Engl J Med 2009; 361: 878-887. Go to original source... Go to PubMed...
    3. Widimský J. Kardiovaskulární skandál č. 1 - špatná léčba hypertenze v populaci. Cor Vasa 2003; 45: 530-532.
    4. Widimský J. Klady a úskalí "evidence based" medicíny. Cor Vasa 2006; 48: 24-31. Go to original source...
    5. Jerie P. Úskalí klinického zkoušení nových léků. Čas Lék Čes 1999; 138: 632-637.
    6. Julius S. Worldwide trends and shortcomings in the treatment of hypertension. Amer J Hypert 2000; 13: 57S-61S. Go to original source... Go to PubMed...
    7. Milliez P. Pharmacologie clinique des antihypertensurs. SANDOZ Editions, Rueil-Malmaison 1973.
    8. McMahon FG. Management of essential hypertension. Futura Publish. Company, Inc. Mount Kisco, New York 1978.
    9. Laragh JH Hypertension manual. Yorke Medical Books, New York 1974, 934 s.
    10. Armstrong ML, Bakke JL, Freis ED et al. A double blind control study of antihypertensive agents. Veterans Administration Cooperative Study. Washington, DC. Arch Int Med 1960; 196: 81-96.
    11. Gross F, Robertson JIS (eds). Arterial Hypertension. Pitman Medical, New York 1980: 1-9.
    12. WHO. Hypertension control. WHO Technical Report Series 862. WHO Geneva 1996.
    13. Widimský J et al. Hypertenze. 3. vydání. Praha: Triton 2008.
    14. Moredge JH, Ettinger B, Aranda J. Isolated systolic hypertension in the elderly. J Am Geriatr Soc 1986; 34: 199-206. Go to original source... Go to PubMed...
    15. Dustan HP. Isolated systolic hypertension: A long-neglected cause of cardiovascular complications. Am J Med 1999; 86: 368-369. Go to original source... Go to PubMed...
    16. Jerie P. Co je arteriální hypertenze? Bilance padesáti let výzkumu a racionální léčby. Čas Lék Čes 1998; 137: 739-742.
    17. Barlow DTC. Appropriate therapy of hypertension in "the elderly". Am Heart J 1978; 95: 809-810. Go to original source... Go to PubMed...
    18. Farnett L, Mulrow CD, Lind WD et al. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 1991; 265: 489-495. Go to original source... Go to PubMed...
    19. Hansson L, Zanchetti A, Caruthers SG et al. Effects of intensive blond-pressure lowering and low dose aspirin with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762. Go to original source... Go to PubMed...
    20. Anonym. HOT Study interim results. Astra AB, Oxford Clin Communications Oxford 1996, 4.
    21. Hansson L. How far should blond pressure be lowered? What is the role of the J-curve? Am J Hypertension 1990; 3: 726-729. Go to original source... Go to PubMed...
    22. Kaplan N. J-curve not burned off by HOT study. Lancet 1998; 351: 1748-1749. Go to original source... Go to PubMed...
    23. Messerli FH. Low blond pressure is associated with increased cardiovascular morbidity (J-shaped curve) in treated hypertensive patients with increased cardiovascular risk: The VALUE randomized trial. Proceedings from the 58th annual session of the ACC in Orlando 2009. J Am Coll Cardiol 2009; 535: A 46 (No 2511-586).
    24. Bulpitt CJ, Becket NS, Cooke J et al. Results of the pilot study for the hypertension in the Very Elderly Trial. J Hypertens 2003; 21: 2409-2417. (HYVET I) Go to original source... Go to PubMed...
    25. Beckett NS, Peters R, Fletcher A. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1897 (HYVET II). Go to original source... Go to PubMed...
    26. Jozifová M, Cífková R, Škodová Z et al. Porovnání léčby hypertenze a rizikového profilu hypertoniků v obecné populaci a na specializovaném pracovišti. Cor Vasa 2003; 45: 533-541.
    27. Jerie P, Lasance A. The characteristics of hypertension in the elderly: Methodological consequences for clinical trials. International Symposium, Montreux, Switzeland, March 30-April 2, 1987: Aging and clinical problems in the elderly.
    28. Widimský J, Jandová R. Longitudinální prognóza juvenilní hypertenze. Čas Lék Čes 1975; 115: 291-297.
    29. Vančura A. Vysoký krevní tlak. Praha: Melantrich 1949.
    30. Timio M, Verdecchia P, Ronconi M et al. Blond pressure changes over 20 years in nuns in a secluded order. J Hypertens 1985; 3 (Suppl 3): 387-388.
    31. Widimský J. Léčba velmi starých hypertoniků snižuje významně riziko celkové mortality i úmrtí na cévní a mozkové příhody. Výsledky studie HYVET. Cor Vasa 2008; 50: 354-357.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.